AKBM: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER

21 Feb 2025 17:41 CET

February 21, 2025 – Trond Atle Smedsrud, CEO Emerging Business, Aker BioMarine,
purchased 6000 shares in Aker BioMarine ASA at an average price of NOK 66 per
share on February 21 through his wholly-owned investment company Hawi Holding
AS. The shares were acquired on Oslo Børs. Following the transaction, Smedsrud
holds a total of 10 410 shares in Aker BioMarine ASA.

For further information, please contact
Christopher Robin Vinter, VP Strategic Finance & IR
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.

About Aker BioMarine:
Aker BioMarine is a leading human health and nutrition innovator that develops
krill-derived products for consumer health and nutrition. Krill is a natural,
powerful, and health-promoting source of nutrients from the pristine waters of
Antarctica, and Aker BioMarine has a unique position in its industry. The
ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and
PL+, as well as the consumer brand, Kori Krill. The innovative approach also
extends into the spin-offs AION (reduce and recycle plastic waste across
industries) and Understory (a protein brand). Aker BioMarine is listed on the
Oslo Stock Exchange (AKBM). More information is available at
www.akerbiomarine.com.

More information:
Access the news on Oslo Bors NewsWeb site

639480_Skjema for melding om transaksjoner utført av personer med ledelsesansvar («primærinnsidere») og deres nærstående (KRT-1500).pdf